ZyVersa Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.3	0.1	1.53	3.14	5.9	0.33
Cash & Short-Term Investments	0.3	0.1	1.53	3.14	5.9	0.33
Cash Growth	-81.22%	-93.35%	-51.21%	-46.84%	1696.27%	88.11%
Prepaid Expenses	0.44	0.23	0.18	0.22	0.23	0.11
Other Current Assets	-	0.01	-	-	0.24	0.38
Total Current Assets	0.74	0.35	1.72	3.35	6.36	0.81
Property, Plant & Equipment	-	-	-	0.01	0.12	0.03
Goodwill	-	-	-	-	11.9	-
Other Intangible Assets	-	-	18.65	18.65	100.09	-
Long-Term Deferred Charges	-	-	0.06	-	-	-
Other Long-Term Assets	-	-	0.18	0.1	0.05	0.29
Total Assets	0.74	0.35	20.6	22.11	118.51	1.13
Accounts Payable	10.24	10.12	9.34	8.43	6.03	2
Accrued Expenses	3.3	2.55	1.89	1.25	0.8	0.75
Current Portion of Long-Term Debt	-	-	-	-	-	9.15
Current Portion of Leases	-	-	-	0.01	0.11	-
Current Income Taxes Payable	-	-	-	-	0.11	-
Other Current Liabilities	0.13	0.06	0.01	0.51	1.15	1.73
Total Current Liabilities	14.87	12.73	11.23	10.19	8.19	13.63
Long-Term Deferred Tax Liabilities	-	-	0.85	0.84	10.32	-
Other Long-Term Liabilities	-	-	-	-	0.33	0.33
Total Liabilities	14.87	12.73	12.08	11.04	18.84	13.96
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	125.26	125.2	121.16	114.3	104.58	40.07
Retained Earnings	-139.38	-137.58	-112.63	-103.22	-4.92	-52.9
Treasury Stock	-0.01	-0.01	-0.01	-0.01	-	-
Total Common Equity	-14.12	-12.39	8.52	11.07	99.66	-12.83
Shareholders' Equity	-14.12	-12.39	8.52	11.07	99.66	-12.83
Total Liabilities & Equity	0.74	0.35	20.6	22.11	118.51	1.13
Total Debt	1.2	-	-	0.01	0.11	9.15
Net Cash (Debt)	-0.9	0.1	1.53	3.13	5.79	-8.82
Net Cash Growth	-	-93.35%	-51.07%	-45.99%	-	-
Net Cash Per Share	-0.12	0.02	1.38	32.09	0.25	-3.65
Filing Date Shares Outstanding	8.1	8.1	2.57	0.83	0.12	24.17
Total Common Shares Outstanding	8.1	8.1	2.51	0.41	0.03	24.17
Working Capital	-14.12	-12.39	-9.52	-6.84	-1.83	-12.81
Book Value Per Share	-1.74	-1.53	3.40	27.33	3868.91	-0.53
Tangible Book Value	-14.12	-12.39	-10.13	-7.57	-12.32	-12.83
Tangible Book Value Per Share	-1.74	-1.53	-4.04	-18.69	-478.20	-0.53
Machinery	-	-	-	0.05	0.05	0.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.